brand-logo

Accelerating the future of human health and wellness

Accelagen is a leading Contract Research Organisation (CRO) headquartered in Australia that works with innovative clients across the globe to make a tangible impact on the future of human health and wellness.

Elevating purpose and putting people first

What makes us different to other Contract Research Organisations (CRO) is our unique approach and process. We are guided by our purpose to co-create meaningful outcomes that positively impact the future of human health and wellness. 

We start by understanding your story – where you are at in the journey and the broader context of the impact you hope to have. And, like time travellers, we jump ahead to a point in time where we can clearly see the desired outcomes where, with years of experience and expertise, we co-create a ‘reverse journey map’ roadmapping the best pathway, the right pathway to get there together. This means a bespoke and tailored strategic approach that ensures we’re offering the right skill sets, expertise and services and that your time and money is spent in the right places.

Contract Research Organisation (CRO)

Lasting partnerships

Our focus is on building lasting partnerships and transparent relationships. Unlike typical contract research organisations (CROs), our projects are not a transaction. Rather, a true collaboration where we involve our experts along the entire journey from concept through to commercialisation.

Contract Research Organisation (CRO)

Our people

Putting people first, our unique approach results in meaningful outcomes that have a tangible impact on the future of human health, co-created with you every step of the way. Our team consists of respected thought-leaders in their fields, with years of success and broad therapeutic and operational experience locally and internationally.

Contract Research Organisation (CRO)

Our values

We are proud to live our values of passion, dedication, agility, integrity and care through the work we deliver and the culture we’ve created. Additionally, we aim to collaborate with like-minded teams to make a difference to the future of human health.

What we offer

Testimonials

"Helping you achieve successful approval We approached Accelagen as we needed additional resources to complete our project. As a result of their assistance and advice, we were able to complete the necessary tasks required to achieve a successful marketing approval.

Jeremy Paull Starpharma

"Steering you through the research process Working with Accelagen was instrumental in helping us create a clear pathway to marketing approval. I can’t thank the team enough for steering us through the process and helping us all the way to a successful outcome!

Robert Klupacs Bionics Institute

Testimonials

"Helping you achieve successful approval We approached Accelagen as we needed additional resources to complete our project. As a result of their assistance and advice, we were able to complete the necessary tasks required to achieve a successful marketing approval.

Jeremy Paull Starpharma

"Steering you through the research process Working with Accelagen was instrumental in helping us create a clear pathway to marketing approval. I can’t thank the team enough for steering us through the process and helping us all the way to a successful outcome!

Robert Klupacs Bionics Institute

"Support and guidance every step of the way At the time we engaged with Accelagen as our Contract Research Organisation, we were unsure how to maximise the outcomes from our development program. Fortunately their team was able to support and guide us in setting a path to achieve our company goals.

Glenn Gilbert Rhythm Biosciences

Latest news

Latest news

Welcoming our new Business Planning and Analysis Manager

Welcoming our new Business Planning and Analysis Manager   Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education, an ASX top 100 company, where he excelled in financial reporting and business analysis. […]

Read More
Hands operating syringe
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results

Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results Local CRO, Accelagen, attracts innovative European drug and antibody developers to trial in Australian market Engaged by world-renowned European clients and collaborators, Memo Therapeutics AG (“MTx”) based in Switzerland, and Vakzine Projekt Management GmbH (VPM) based […]

Read More
Amritha
Accelagen Staff Announcement: Amritha Vangur

Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again! Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate. Amritha first worked at Accelagen in 2019. The company was in its infancy at the time, with a small, tight-knit team. Shortly after joining, Amritha travelled overseas and […]

Read More

Leading the way​

0
Device Approvals
0
Category 1 Applications
0
ODD Submissions
0
TGA Meetings
0
CTN Submissions
0
Clinical Trial Sites
0
Dossierrs Reviewed
0
IND/IDE Submissions

Experience the Accelagen difference and unlock the future of human health